Advent Pharma Ltd., a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 2004, the company has achieved notable milestones, positioning itself as a trusted provider of high-quality medicines and healthcare solutions. Specialising in the development and manufacturing of generic pharmaceuticals, Advent Pharma offers a diverse portfolio that includes formulations for chronic and acute conditions. Their commitment to innovation and quality sets them apart in a competitive market, ensuring that they meet the evolving needs of healthcare professionals and patients alike. With a strong focus on research and development, Advent Pharma Ltd. has garnered recognition for its contributions to the industry, solidifying its market position as a reliable source of effective and affordable medications.
How does Advent Pharma Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Advent Pharma Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Advent Pharma Ltd., headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available at this time. As a result, Advent Pharma Ltd. appears to be in the early stages of establishing its climate commitments and emissions reporting. Without specific emissions data or reduction initiatives, it is unclear how the company plans to address its carbon footprint or align with industry standards for sustainability. In the context of the pharmaceutical industry, companies are increasingly expected to set science-based targets and commit to reducing their greenhouse gas emissions across all scopes. However, without available data or commitments, Advent Pharma Ltd. has yet to demonstrate its approach to climate action.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Advent Pharma Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.